Objective-Wound monocyte-derived macrophage plasticity controls the initiation and resolution of inflammation that is critical for proper healing, however, in diabetes mellitus, the resolution of inflammation fails to occur. In diabetic wounds, the kinetics of blood monocyte recruitment and the mechanisms that control in vivo monocyte/macrophage differentiation remain unknown. Hi cells demonstrated differences in proinflammatory and profibrotic genes compared with controls. Conclusions-Collectively, these data identify kinetic and functional differences in diabetic wound monocyte/macrophages and demonstrate that selective targeting of CD11b
I mpaired wound healing in diabetes mellitus is presently the leading cause of lower extremity amputation in the United States and costs the healthcare system >$19 billion dollars annually. Importantly, amputation is associated with a 50% mortality rate at 5 years, a survival rate worse than most cancers.
1,2 Impaired wound healing in diabetes mellitus is multifactorial because of a combination of peripheral artery disease, peripheral neuropathy, inflammation, and altered immune cell function. 3 Peripheral artery disease is present in over half of patients with diabetic wounds and contributes significantly to impaired healing. 4 Persistent, uncoordinated inflammation is a hallmark of chronic nonhealing wounds in diabetes mellitus. 5 Our laboratory and others have found increased inflammatory macrophages in diabetic wounds when anti-inflammatory macrophages should predominate to help drive tissue repair, however, the mechanisms that sustain the inflammatory macrophage phenotype in diabetic wounds has not been identified. [5] [6] [7] [8] [9] [10] [11] [12] The recruitment of circulating blood monocytes to the site of tissue injury plays a critical role in tissue repair through the coordination of inflammation. The precise timing of both the initiation and resolution of inflammation is essential for restoring tissue integrity. The first phase of the inflammatory response is destructive to the tissue and promotes clearance of invading pathogens, whereas the second phase is a resolution phase where tissue repair ensues. 13, 14 For this reason, inflammation is an adaptive process that is necessary to maintain tissue homeostasis. [15] [16] [17] In the absence of precise programmed inflammation, pathological nonhealing ensues. 6, 10, [18] [19] [20] Infiltrating blood monocyte-derived macrophages (monocyte/macrophages) are critical for the initial inflammatory phase of wound healing and play a key role in the orchestration of subsequent phases. 13, [21] [22] [23] Blood monocytes originate from macrophage-dendritic cell (DC) precursors in the bone marrow and ultimately differentiate into macrophages and NK1.1 Hi monocyte/macrophages, we show Ly6C
Hi cells transition to a Ly6C
Lo phenotype in normal wounds, whereas in diabetic wounds, there is a late, second influx of Ly6C Hi cells demonstrated differences in proinflammatory and profibrotic genes compared with controls. Conclusions-Collectively, these data identify kinetic and functional differences in diabetic wound monocyte/macrophages and demonstrate that selective targeting of CD11b
DCs in the tissues. 22, 24, 25 Given the shared origin between these more differentiated cell progeny, there has been considerable debate about the definitions of these separate cell populations because they retain many of the same surface markers and display overlapping functions. 26 In addition, these definitions are further complicated by the recent discovery of resident macrophages (CD11b + /F4/80 + ) which populate the tissues before birth and persist through self-replication. 27 Although there is some literature on the role of resident macrophages and DCs in wound healing, there is growing evidence that infiltrating monocyte/macrophages provide the mandatory drive for acute inflammation and subsequently orchestrate the process of repair. 10, 14, 21, 22, [28] [29] [30] [31] [32] [33] Despite this evidence of the importance of recruited blood monocyte/macrophages, because of lack of consensus definitions and the recent realization that many of the markers previously used to define recruited monocyte/ macrophages actually label resident macrophages, few studies have directly examined the in vivo characteristics of the true recruited monocyte/macrophage population. Among blood monocytes, specific identifiable subsets with distinct effector functions have now been identified. 34 Lo murine monocytes, respectively. 13, 34, 37, 38 Although many in vitro studies using monocyte/macrophages have demonstrated high plasticity, little is known about the wound in vivo cell plasticity. 26 Unfortunately the majority of wound healing literature to date has relied on in vitro definitions of M1 and M2 macrophages, making the application to in vivo studies purely speculative. 7 Although significant strides have been made in recognizing the contribution of blood monocyte-derived macrophages to tissue repair, it remains challenging to study monocyte/macrophage polarity/ plasticity in vivo because of a lack of consensus on nomenclature, cell-marker definitions, and debate over effector-cell origin. 7, 26 Hence, a careful evaluation of infiltrating monocyte/ macrophage subsets in wound granulation tissue is necessary to effectively compare monocyte/macrophage plasticity in both normal and diabetic tissue.
To first define the kinetics of blood monocyte/macrophage subsets in normal and diabetic wound healing, we evaluated Ly6C
Hi [ 
Ly6C
Hi cell influx in diabetic wounds improves wound healing without the adverse effect of global monocyte depletion. These findings extend mechanistic insight into the dynamic functions of monocyte-derived macrophages during both normal and diabetic tissue repair.
Materials and Methods
The data that support the findings of this study are available from the corresponding author on reasonable request. Details for major experimental resources can be found in Table I in the online-only Data Supplement.
Mice
Male C57BL/6 mice (Jackson Laboratory, Bar Harbor, ME) were maintained in breeding pairs at the University of Michigan Unit for Laboratory and Animal Medicine. Male offspring were maintained on a standard normal rodent diet (13.5% kcal saturated fat, 28.5% protein, 58% carbohydrate; Lab Diet) or standard high-fat diet (60% kcal saturated fat, 20% protein, 20% carbohydrate; Research Diets, Inc) for 12 weeks to induce the diet-induced obese (DIO) model of type 2 diabetes mellitus as previously described. 39 Only male C57BL/6 mice develop obesity/glucose intolerance on high-fat diet, thus females cannot be used as a model of obesity/insulin resistance. 
Wound Model
Mice were anesthetized, dorsal fur was removed with Veet hair removal cream, and the skin was cleaned with sterile water. Full thickness 4-mm punch biopsies were used to create wounds on the midback as described previously.
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Assessment of Wound Healing
Wound healing was monitored daily using digital photography with an 8MP iPad camera as described previously. 10 Wound areas were 
Wound Cell Isolation
Wounds were harvested with a 6 mm punch biopsy to afford a 1 to 2 mm margin. Wounds were chopped, digested with Liberase TL (Sigma-Aldrich; Cat No. 5401020001)/DNase I (Sigma-Aldrich; Cat No. 9003-98-9) and plunged through a 100 μm nylon filter to yield a single cell suspension.
Ex Vivo Stimulation
Wound cell isolates were plated in Teflon wells and stimulated with LPS (100 ng/mL 
RNA-Sequencing
Two biological replicates from normal rodent diet and high-fat diet mice were surface stained and sorted by FACS into CD11b Lo populations. RNA isolation was performed using a miRNeasy Micro Kit (Qiagen) with DNAse digestion. Because of low RNA yields, library construction was performed using the Clontech SMARTer Pico Kit (Mountain View, CA). Resulting reads were trimmed using Trimmomatic and mapped using HiSAT2. 40, 41 Read counts were performed using the feature-counts option from the subRead package followed by the elimination of low reads, normalization, and differential gene expression using edgeR. 42 45 were used. All reads were mapped to the mm 10 genome. Differential expression was performed on mapped reads using the tagwise dispersion algorithm in edgeR. 43, 46 Adoptive Transfer
Blood leukocytes from mT/mG mice were passed through a Ficoll gradient and the buffy coat was collected. The mononuclear cell suspension was washed in magnetic-activated cell sorting buffer, labeled with anti-CD3-Biotin, anti-CD19-Biotin, anti-NK1.1-Biotin antibodies (Biolegend), and ultimately, anti-biotin micromagnetic beads (Miltenyi Biotec). The cells were then passed through a magnetic-activated cell sorting column for negative selection. Cells were then surface stained and FACS sorted (as described) to obtain a pure Ly6C Hi population. Approximately 24 hours after wounding, ≈10
Hi blood monocytes were injected via tail vein into control and DIO mice. Wounds and peripheral blood were then collected on day 4 postinjury for flow analysis.
MCP-1 Assay
Wound cells were analyzed for MCP-1 (monocyte chemoattractant protein-1) levels using DuoSt ELISA kit (R&D Systems; Cat No. SMJE00) according to the manufacturer's protocol.
RNA Extraction
Total RNA extraction was performed with Trizol using the manufacturer instructions. Total RNA was reverse transcribed to cDNA using iScript (Biorad). qPCR was performed with 2X Taqman PCR mix using the 7500 Real-Time PCR system. Primers for MCP-1 were purchased from Applied Biosciences. Fold expression was calculated by normalizing to control 18s ribosomal RNA using (2 ΔCt ) analysis. All samples were assayed in triplicate.
Statistical Analysis
GraphPad Prism software version 6 .0 was used to analyze the data. Data are presented as the mean±SEM. Data were first analyzed for normal distribution and then statistical significance between multiple groups was determined using 1-way analysis of variance followed by Newman-Keuls post hoc test. For all other single group comparisons, if data passed normality test, we used 2-tailed Student t test. Otherwise, data were analyzed using Mann-Whitney U test. All data are representative of at least 2 independent experiments. A P value of ≤0.05 was significant.
Results
CD11b
+
Ly6C
Hi Monocyte/Macrophages Rapidly Accumulate After Skin Injury and Transition to CD11b
+
Ly6C
Lo Macrophages
Monocyte/macrophages are highly plastic in their roles in acute inflammation, and hence, possess dichotomous roles in both tissue destruction and tissue repair after injury. 23, 32 Given the opposing effector functions of distinct cell subsets, a high degree of regulation is necessary for proper repair of injured tissue. 19 Indeed, there is a growing body of evidence that suggests infiltrating monocyte/macrophages contribute significantly to inflammatory conditions, including diabetes mellitus, because of an imbalance of pro-and anti-inflammatory monocyte/ macrophages. 8 Hi and CD11b + Ly6C Lo cells were determined as shown in the density plot ( Figure 1A ). There is a clearly identifiable CD11b + Ly6C
Hi and CD11b
Lo population at each time point in the wounds, consistent with data from other organs ( Figure 1B) . 23 The relative proportions of the CD11b + Ly6C
Hi and CD11b Hi monocyte/macrophages in the wounds (≈80:20 at 24 hours), however, eventually the CD11b
Lo cohort dominates around 48 hours ( Figure 1C ). To confirm our focus on infiltrating monocyte/ macrophages and not resident macrophages (CD11b
we examined resident tissue macrophages in our wound granulation tissue and found that they were a small percentage of cells that did not influence our CD11b
Hi cells in wounds ( Figure I in the online-only Data Supplement). In addition to the changes in myeloid cell subsets in wounds overtime, these findings demonstrate the ability to track and compare 2 independent monocyte/macrophage populations in wounds. Lo monocyte/macrophages ( Figure 2A ). Selectively, percentages and mean fluorescence intensity (MFI) of TNF-α and IL (interleukin)-1β-producing cells were calculated from the Ly6C Hi and Ly6C Lo populations ( Figure 2B ). An FMO (fluorescence minus one) control was used to verify the accuracy of gate placement ( Figure 2C Lo cells could contribute to the pathological inflammation seen in diabetes mellitus. 10, 19 To address this, a physiological murine model of type 2 diabetes mellitus (DIO; 60% saturated fat diet) was used. The DIO model was used as opposed to other models of type 2 diabetes mellitus because of its lack of alterations in the innate immune system. [47] [48] [49] Similar to normal control mice ( Figure 1B and 1C) , the DIO wounds demonstrated an early influx of CD11b
Wound
Hi monocyte/macrophages that transitioned to CD11b
Lo monocyte/macrophage dominance around 48 hours. However, in the DIO wounds, there was a second influx of CD11b
Hi monocyte/macrophages between days 3 and 4 postinjury that persisted until day 7 ( Figure 3A) . Furthermore, when comparing percentages of CD11b +
Ly6C
Hi monocyte/macrophages postinjury between control and DIO mice, at day 4, CD11b +
Hi monocyte/ macrophages represented 22.2% in control mice and 54.3% in DIO mice ( Figure 3B ). There were no changes in overall Hi monocyte/macrophages in DIO wounds at late time points is consistent with previously published data demonstrating increased inflammatory macrophages in diabetic wounds. 8, 10, 12 To evaluate whether the second influx of CD11b + Ly6C
Hi monocyte/macrophages retain their proinflammatory phenotype in late DIO wounds, we performed intracellular flow cytometry for TNF-α and IL-1β. CD11b +
Hi monocyte/macrophages were 41.2% and 40.2% positive for IL-1β and TNF-α, whereas CD11b + Ly6C
Lo monocyte/macrophages were 9.4% and 18.4% positive, respectively. In parallel, the MFI of IL-1β and TNF-α in the Ly6C
Hi gate was significantly increased compared with the Ly6C
Lo gate ( Figure 3C ). To compare changes in wound Ly6C populations with changes in CD11b 50 we found that there is an increase in peripheral blood CD11b + Ly6C
Hi cells after injury. Further, when we looked at differences in peripheral blood CD11b +
Hi cells between wounded control and DIO mice, there were significantly less CD11b + Ly6C
Hi cells in DIO peripheral blood at day 4 postinjury. This suggests that these blood cells may be rapidly recruited to the site of injury in DIO mice and result in an inverse relationship in CD11b + Ly6C
Hi cell numbers in peripheral blood and wound tissue. Taken together, these findings suggest that the increased inflammatory phenotype seen in diabetic wounds is secondary to increased CD11b phenotype, we performed a series of adoptive transfer experiments. Specifically, control and DIO mice were wounded at time zero and ≈24 hours later underwent adoptive transfer with 10 6 CD11b + Ly6C Hi blood monocytes harvested from mT/mG mice (Gt(ROSA)26Sor
tm4(ACTB-tdTomato,-EGFP)Luo
/J). Wounds were harvested on day 4 (gating strategy identical to Figure 2A Figure 4B ). Taken together, these findings suggest that the proinflammatory CD11b +
Ly6C
Hi monocyte/ macrophage predominance in DIO wounds is related to both an increased recruitment and impaired differentiation of CD11b
Hi cells in a diabetic setting. ] monocyte/macrophages represent more of a hybrid picture between in vitro M1 and M2 macrophages, it is possible that the use of traditional in vitro macrophage characterization for this cell population in wound healing is not practical, as has been previously suggested. 21 These findings are highly relevant as they will allow for more accurate immunophenotyping of wound monocyte/ macrophages and identify new avenues for therapy. To test the similarity of in vivo monocyte subsets isolated from wounds to traditional in vitro macrophages, we compared the entire transcriptome from each data set ( Figure 5C ). Figure 5C shows the Pearson correlation for all differentially expressed genes. These data confirm the analysis performed in Figure 5A and 5B and further demonstrate that the in vivo subsets display a distinct profile in comparison to in vitro macrophages.
Because diabetic wounds demonstrate increased recruitment of infiltrating Ly6C
Hi [Lin Hi wound cells differ in transcriptome from control wound CD11b +
Hi monocyte/macrophages. Using edgeR analysis and hierarchical clustering, we found a significant discord between CD11b +
Hi monocyte/macrophages from control and diabetic wounds. Many of these genes are important in inflammation and collagen formation and are thus, important for wound healing (Table II in 
Timed Treatment of Diabetic Mice With Anti-MCP-1 Antibody Postinjury Restores Normal Healing
To examine the mechanism responsible for increased CD11b +
Ly6C
Hi monocyte/macrophages in diabetic wounds, we first identified chemotactic factors that may drive increased recruitment of monocytes from peripheral blood. MCP-1 (CCL2 [C-C motif ligand 2]) is the ligand to the monocyte chemokine receptor CCR2 (C-C chemokine receptor type 2) and is necessary for recruitment of blood monocytes to inflamed tissues. 21, 34 Hence, we measured levels of MCP-1 in control and DIO wound cells at a time point during the second CD11b + Ly6C
Hi influx in diabetic wounds. − cells (wound macrophages as previously defined by our group and others) compared with controls on day 5 following injury ( Figure 6A ; Figure VII in the online-only Data Supplement). 10, 12, 52, 53 This increase in DIO wound MCP-1 at day 5 is accompanied by increased CD11b +
Hi monocyte/ macrophage counts in DIO wounds at day 6 ( Figure 6B ).
Prior work in murine models of diabetes mellitus has demonstrated impaired wound healing secondary to increased inflammation. 8, 10, 12 Given that we found a potential mechanism for increased inflammation in diabetic wounds through the excessive recruitment and retention of CD11b Hi monocyte/macrophages), injected with either normal rabbit serum or purified rabbit anti-mouse MCP-1 antibody (anti-MCP-1) and wound healing was monitored. Anti-MCP-1 injected DIO mice demonstrated significantly improved wound healing compared with normal rabbit serum-injected controls ( Figure 6C ). As expected, in control mice, anti-MCP-1 injection did not significantly alter wound healing, although there was a trend toward impaired healing in the anti-MCP-1 injected mice ( Figure 6D ). This is similar to other studies demonstrating that impairing monocyte recruitment in normal wound healing is detrimental to healing. 21 Further, when wounds were harvested 2 days after anti-MCP-1 injection, there was a clear reduction in the CD11b + Ly6C
Hi cells, suggesting that the improved wound healing seen in the DIO mice after anti-MCP-1 injection correlates with reduced CD11b
Hi monocyte/macrophages ( Figure 6E and 6F) . Additionally, when we examined the blood, there was a trend toward decreased CD11b Lo cells in both the normal and DIO blood after anti-MCP-1 injection ( Figure VIII in the online-only Data Supplement). These findings suggest that careful and time-dependent antibody-mediated control of monocyte/macrophage influx after injury may represent a novel therapeutic target for impaired diabetic wound healing.
Discussion
Infiltrating peripheral blood monocyte/macrophages are necessary for the maintenance of tissue homeostasis postinjury. 11, 15 Monocyte/macrophages are highly plastic in their roles in acute inflammation, and hence, possess dichotomous roles in both tissue destruction and tissue repair after injury. 23, 32 Given the opposing effector functions of distinct subsets, a high degree of regulation of these cells is necessary for proper repair of injured tissue. 19 Indeed, there is a growing body of evidence that suggests infiltrating monocyte/macrophages contribute significantly to inflammatory conditions, including diabetes mellitus, because of an imbalance of pro-and anti-inflammatory cells. 8, 10, 12, 23, 30 Although this is widely accepted, the kinetics of myeloid cell subset influx in wound healing overtime has remained elusive. Further, the definitions of these cell populations remain elusive, with many previous in vivo cell characterizations based on the inclusion of resident macrophages (CD11b + / F4/80 + ). 22, 26, 34 These resident macrophages arise from a separate nonhematopoietic cell lineage, are present at birth and self-renew in the tissues, making them fundamentally distinct from the blood-derived infiltrating monocyte/macrophages that are recruited to tissues after injury. 27, 31 Thus, there is little existing literature that examines the phenotype and role of these infiltrating monocyte/macrophages after injury. Hence, we chose a model of wound healing in which we would collect granulation tissue (arguably devoid of resident macrophages; Figure I in ] monocyte/macrophages for RNA-sequencing (RNA-seq). RNA samples were processed by the National Institutes of Health-funded, University of Michigan DNA sequencing core. Reads were trimmed using Trimmomatic and mapped using HiSAT2. Read counts were performed using the featureCounts option from the subRead package followed by the elimination of low reads and normalization using edgeR. For comparison to in vitro generated macrophages, M1 [IFNγ] Lo monocyte/macrophages in wound healing in physiological and diabetic conditions, and have found mechanisms for increased inflammation in diabetic wound healing secondary to an increased influx of CD11b Lo cells. Interestingly, we found an increased number of circulating CD11b + Ly6C
Hi monocytes in control wounded mice and when comparing control and DIO wounded mice, there were less circulating CD11b
Hi cells in DIO mice although there were more CD11b
Hi cells in DIO wounds-suggesting a yin-yang phenomenon in monocyte recruitment in diabetes mellitus. Although this could represent a poor mobilization of splenic and bone marrow-derived monocytes in diabetic mice, it has been demonstrated previously that in the setting of intact CCR2-MCP1 signaling, there is robust mobilization of CD11b
Hi monocytes from bone marrow and spleen after injury. 50, 56 Additional mechanisms of increased inflammation in diabetic wounds were demonstrated herein using RNA-based transcriptome profiling, where we found that the transcriptome of diabetic wound CD11b +
Ly6C
+
Ly6C
Lo monocyte/macrophages differs from control cells with respect to proinflammatory and profibrotic gene expression. Importantly, these transcriptome-based studies identify an accurate way to immunophenotype monocyte/ macrophages in the wound and may provide a benchmark for response to therapy. Additionally, we have found that a selective, timed injection of anti-MCP-1 antibody resulted in improved wound healing in diabetic mice; suggesting at least a partial amelioration of the impaired wound healing phenotype.
Previous studies have drawn loose comparisons between in vivo wound monocyte/macrophages and classical or alternative in vitro macrophages. 5, [8] [9] [10] Because it is not clear that in vivo wound monocyte/macrophage subsets fit discrete in vitro definitions, 7, 21 we performed a full transcriptome analysis of both diabetic and control wound monocyte/ macrophages. Using RNA-seq, we found that the transcriptome of Ly6C
Hi [Lin − Ly6G − CD11b + ] monocyte/macrophages extracted from normal wounds do resemble in vitro M1[LPS,IFNγ] macrophages. Ly6C
Lo [Lin − Ly6G − CD11b + ] monocyte/macrophages, however, do not resemble M2 in vitro macrophages. Taken together with our RNA-seq data, this suggests that Ly6C is important in immunophenotyping wound monocyte/macrophages. These findings are highly relevant as they will allow for accurate immunophenotyping and promote caution in drawing comparisons between in vivo wound monocyte/macrophages and traditional in vitro macrophages.
Although this article addresses important issues with regards to the fundamental biology of blood monocyte influx and its relation to wound phenotypes, there are some limitations. First, wound monocyte/macrophages are inextricably related to wound DCs and they are tedious to define with traditional flow cytometry. 22 Thus, it is conceivable that some of our findings are related to wound DCs, however, given the homogenous character of our RNA-seq data between biological replicates, this is unlikely to be relevant. Lo cells are predisposed to form CD206 + repair macrophages in wound tissues. Finally, with regard to our translational finding that blocking the MCP-1/CCR2 axis improves late wound healing in diabetes mellitus, the previous study by Willenborg et al 21 suggests that this leukocyte recruitment mechanism is essential for normal wound healing. We agree with this and feel that our findings complement this study, as we found that the timing of MCP-1/CCR2 blockade is important because initial inflammation is critical for proper wound healing.
Our findings herein are both novel and timely, as recent literature has highlighted the importance of blood monocyte/macrophage heterogeneity in health and disease. 35, 58 Additional questions remain as to whether blood monocyte chemotaxis modulation or control of monocyte/macrophage phenotype transition will be effective in treating inflammatory conditions. With new research focused on monocyte/ macrophage heterogeneity in wounds, it is foreseeable that an improved understanding of chronic inflammatory conditions will lead to new, desperately needed therapeutics. Figure 6 Continued. serum (NRS) or purified rabbit anti-mouse MCP-1 antibody (anti-MCP-1) and wound healing was monitored until wound closure. Wound curves were generated as percent of initial wound area. (*P<0.05, **P<0.01; n=10 wounds per group). D, Control mice were wounded with a 4-mm punch biopsy and wound healing was monitored daily using an 8MP iPad camera, internal scale, and NIH ImageJ software. At day 3 postinjury, mice underwent intraperitoneal injection with either normal rabbit serum (NRS) or purified rabbit anti-mouse MCP-1 antibody (anti-MCP-1) and wound healing was monitored until wound closure. Wound curves were generated as percent of initial wound area. (n=10 wounds per group). E and F, DIO mice were wounded with a 4-mm punch biopsy and on day 3 postinjury, mice underwent intraperitoneal injection with either NRS or purified rabbit anti-mouse MCP-1 antibody (anti-MCP-1). Wounds were harvested on day 5 and analyzed by flow cytometry. Gating was identical to that shown in Figure 2 
